No CA n = 12 | CA n = 14 | P value | ||
---|---|---|---|---|
Age (years) | Median (min, max) | 6.8 (4.1, 15.9) | 13.6 (4.5, 17.8) | 0.015 |
Sex (%) | Males | 11 (92) | 7 (50) | 0.036 |
Parental smokers (%) | Total | 1 (8) | 2 (14) | 1.000 |
Previous adrenaline required (%) | Total | 0 (0) | 6 (43) | 0.017 |
Other food allergy (%) | Total | 6 (50) | 5 (36) | 0.692 |
AR (%) | Total | 9 (75) | 8 (57) | 0.429 |
AR severity for those with AR—max = 4a | Median (min, max) | 4 (1, 4) | 3 (1, 4) | 0.698 |
Eczema ever (%) | Total | 12 (100) | 10 (71) | 0.478 |
Eczema active treatment (%) | Total | 7 (58) | 5 (36) | 0.431 |
SCORAD for those with visible eczema | Median (min, max) | 19.2 (3.0, 28.9) | 7.4 (3.4, 24.4) | 0.460 |
Asthma ever (%) | Total | 9 (75) | 8 (57) | 0.429 |
Current preventer (%) | Total | 8 (67) | 3 (21) | 0.045 |
Current reliever (%) | Total | 8 (67) | 7 (50) | 0.453 |
Further exposure to peanut since challenge (%) | Total | 12 (100 %) | 0 (0 %) | <0.0001 |
Still eating peanuts at time of follow-up (%)b | Total | 10 (83 %) | 0 (0 %) | <0.0001 |
Ara h2 SPT (mm) (min, max) | Median (min, max) | 2.3 (0.0, 5.0) | 6.5 (2.0, 9.0) | 0.0001 |
Peanut SPT (mm) (min, max) | Median (min, max) | 4.0 (0.0, 8.5) | 8.0 (5.0, 13.0) | 0.0004 |
Ara h2 sIgE (kU/L) | Median (min, max) | 0.08 (0.00, 4.79) | 2.21 (0.41, 22.1) | <0.0001 |
Peanut sIgE (kU/L) | Median (min, max) | 0.31 (0.01, 35.60) | 2.84 (0.32, 23.3) | 0.0073 |
FeNO (p.p.b)c | Median (min, max) | 9.6 (2.7, 40.0) | 42.1 (15.2, 119.2) | 0.0018 |